4-vinyl-2,6-dimethoxyphenol has been researched along with Carcinogenesis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Liao, L; Maeda, H; Nakamura, H; Qin, H; Seki, T; Tsukamoto, T; Yin, H | 1 |
1 other study(ies) available for 4-vinyl-2,6-dimethoxyphenol and Carcinogenesis
| Article | Year |
|---|---|
Protection from inflammatory bowel disease and colitis-associated carcinogenesis with 4-vinyl-2,6-dimethoxyphenol (canolol) involves suppression of oxidative stress and inflammatory cytokines.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carcinogenesis; Colitis; Cyclooxygenase 2; Cytokines; Dextran Sulfate; Female; HEK293 Cells; Heme Oxygenase-1; Humans; Inflammatory Bowel Diseases; Macrophage Activation; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Nitric Oxide Synthase Type II; Oxidative Stress; Phenols; Tumor Necrosis Factor-alpha; Vinyl Compounds | 2013 |